301117 Stock Overview
Provides network information security products and comprehensive information solutions. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Jiayuan Science and Technology Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥33.00 |
| 52 Week High | CN¥67.00 |
| 52 Week Low | CN¥20.72 |
| Beta | -0.12 |
| 11 Month Change | -3.73% |
| 3 Month Change | 45.44% |
| 1 Year Change | -45.42% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -60.66% |
Recent News & Updates
Recent updates
Shareholder Returns
| 301117 | CN IT | CN Market | |
|---|---|---|---|
| 7D | 5.1% | 3.3% | -0.6% |
| 1Y | -45.4% | 6.2% | 3.2% |
Return vs Industry: 301117 underperformed the CN IT industry which returned 7.1% over the past year.
Return vs Market: 301117 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
| 301117 volatility | |
|---|---|
| 301117 Average Weekly Movement | 12.5% |
| IT Industry Average Movement | 11.3% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 301117's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 301117's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 364 | Jin Wang | www.scjydz.com |
Jiayuan Science and Technology Co.,Ltd. provides network information security products and comprehensive information solutions. It serves medical and health care, national defense and military, government services, and other industries.
Jiayuan Science and Technology Co.,Ltd. Fundamentals Summary
| 301117 fundamental statistics | |
|---|---|
| Market cap | CN¥3.04b |
| Earnings (TTM) | -CN¥55.53m |
| Revenue (TTM) | CN¥235.94m |
12.9x
P/S Ratio-54.8x
P/E RatioIs 301117 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301117 income statement (TTM) | |
|---|---|
| Revenue | CN¥235.94m |
| Cost of Revenue | CN¥152.15m |
| Gross Profit | CN¥83.79m |
| Other Expenses | CN¥139.32m |
| Earnings | -CN¥55.53m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.60 |
| Gross Margin | 35.51% |
| Net Profit Margin | -23.53% |
| Debt/Equity Ratio | 0.08% |
How did 301117 perform over the long term?
See historical performance and comparison